Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RegenoGel
- Development stage
- Unknown
- Lead developer
- ProCore Bio
- Modality
- Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes
- Administration
- Intraarticular
01
Overview
RegenoGel is a novel intra-articular viscosupplement and regenerative scaffold developed by ProCore Ltd for the treatment of knee osteoarthritis. It consists of high molecular-weight hyaluronic acid (HA) chemically conjugated to fibrinogen using the proprietary HaProlink technology. Upon injection into the joint and activation by thrombin or tissue factors, the conjugate assembles into a solid, insoluble fibrin-HA hydrogel. This hydrogel provides mechanical protection, enhances viscosupplementation, and serves as a bioactive scaffold to promote stem cell attachment and tissue regeneration. The product exists in two forms: RegenoGel, which utilizes purified human plasma-derived fibrinogen, and RegenoGel-OSP, which utilizes autologous plasma-derived fibrinogen.
- Brand names
- RegenoGel
- Other names
- RegenoGel-OSPfibrin-hyaluronan hydrogelfibrin-HA conjugate
Beyond the preview
Go deeper on RegenoGel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RegenoGel.